Africa injectable drugs market

Africa Injectable Drugs Market, by Molecule Type (Large Molecule and Small Molecule), by Route of Administration (Intravenous, Intramuscular, Sub-cutaneous, and Others, by End User (Hospitals, Specialty Clinics, and Others), and by Country/Region (South Africa, Central Africa, and North Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Jun 2022
CMI4949
175 Pages
Excel & Pdf
Pharmaceutical

Summary

Injectable pharmaceutical drug delivery system can be used as an alternative to oral drug delivery system. An injection is considered a form of parenteral drug administration, and it allows the medication to be absorbed more rapidly.

Africa injectable drugs market is estimated to be valued at US$ 284.5 Mn in 2022 and expected to exhibit a CAGR of 4.7% during the forecast period (2022-2030).

Figure 1. Africa Injectable Drugs Market Share (%) in Terms of Value, by Molecule Type, 2022

The increasing prevalence of chronic diseases such as cardiovascular, diabetes, cancer, etc. is expected to drive the market growth during the forecast period.

Sedentary lifestyle and changes in dietary habits i.e. the consumption of fats and sugar-rich diet lead to an increase in cases of obesity and thereby increase the risk of cardiovascular diseases and diabetes. For instance, according to the International Diabetes Federation, in 2019, an estimated 19.4 million adults aged 20-79 years were living with diabetes in Africa.

Africa Injectable Drugs Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 284.5 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	4.7%	2030 Value Projection:	US$ 410.9 Mn
Geographies covered:	Africa: North Africa, Central Africa, and South Africa
Segments covered:	By Molecule Type: Large Molecule, Small Molecule By Route of Administration: Intravenous, Intramuscular, Sub-cutaneous, Others By End User: Hospitals, Specialty Clinics, Others
Companies covered:	Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.
Growth Drivers:	Increase in the prevalence of chronic diseases Growing manufacturing facilities for pharmaceutical drugs
Restraints & Challenges:	Lack of funding for manufacturing injectable products

Figure 2. Africa Injectable Drugs Market Share (%), by End User, 2022

Growing manufacturing facilities for pharmaceutical drugs are expected to drive the market growth during the forecast period.

The ever-growing number of healthcare practitioners leads to a surge in the demand for injectable drugs. For instance, in Africa estimated there were about 266,279 doctors in 2020. Thus, key market players are engaged in enhancing their manufacturing capabilities and strengthening their position in the market, which will drive the market growth. For instance, in sub-Saharan Africa, only Kenya, Nigeria, and South Africa have a relatively considerable industry with a significant number of manufacturing companies. Moreover, initiatives by governments and market players to develop a local drug industry in sub-Saharan Africa is expected to create a significant opportunity for the market players.

Africa Injectable Drugs Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization (WHO) declared it a public health emergency on January 30, 2020.

The COVID-19 can affect the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets.

Africa Injectable Drugs Market: Restraint

The major factors that hinder the growth of Africa injectable drugs market include the lack of funding for manufacturing injectable products. Lack of finances can also be a significant challenge to manufacturing injectable pharmaceuticals.

Key Players

Major players operating in Africa injectable drugs market include Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.

Table of Content

Table of Contents

*Browse 15 market data tables and 39 figures on "Africa Injectable Drugs Market” - forecast to 2028

Segmentation

Detailed Segmentation:

Africa Injectable Drugs Market, By Molecule Type:
- Large Molecule
- Small Molecule
Africa Injectable Drugs Market, By Route of Administration:
- Intravenous
- Intramuscular
- Sub-cutaneous
- Others
Africa Injectable Drugs Market, By End User:
- Hospitals
- Specialty Clinics
- Others
Africa Injectable Drugs Market, By Country/Region:
- North Africa
  - Molecule Type
    - Large Molecule
    - Small Molecule
  - Route of Administration
    - Intravenous
    - Intramuscular
    - Sub-cutaneous
    - Others
  - End User
    - Hospitals
    - Specialty Clinics
    - Others
- Central Africa
  - Molecule Type
    - Large Molecule
    - Small Molecule
  - Route of Administration
    - Intravenous
    - Intramuscular
    - Sub-cutaneous
    - Others
  - End User
    - Hospitals
    - Specialty Clinics
  - Others
- South Africa
  - Molecule Type
    - Large Molecule
    - Small Molecule
  - Route of Administration
    - Intravenous
    - Intramuscular
    - Sub-cutaneous
    - Others
  - End User
    - Hospitals
    - Specialty Clinics
  - Others

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of Africa injectable drugs market during the forecast period (2022-2030)?

Africa injectable drugs market is estimated to be valued at US$ 284.5 million in 2022 and expected to exhibit a CAGR of 4.7% between 2022 and 2030.

What are the major factors driving the market growth?

Factors such as an increase in the prevalence of chronic disease and number of manufacturing facilities are expected to drive the market growth during the forecast period.

Which is the leading molecule type segment in market?

Small molecule is the leading molecule type segment and is expected to hold a major market share during the forecast period.

What are the key factors hampering the growth of market?

The major factors hampering the growth of the market include the lack of funding for manufacturing injectable products.

Which are the major players operating in the market?

Major players operating in the market include Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.